Martha Bebinger
[Copyright 2024 NPR]
-
People in recovery from opioid or alcohol addiction are weathering a new storm of depression, anxiety and isolation these days, as 12-step programs move online and detox centers close their doors.
-
Despite Trump's public remarks, infectious disease experts say it's premature to think hydroxychloroquine will help against COVID-19. And patients with lupus or rheumatoid arthritis rely on the drug.
-
When patients need long-term treatment with IV antibiotics, hospitals usually let them do it at home — but not if they have a history of injection drug use. A Boston program wants to change that.
-
The state now requires women and girls under 18 to obtain permission from their parents or a judge. But in a recent poll, most Massachusetts voters favored letting minors decide on their own.
-
Public health officials are adopting a law-enforcement tool, the mass spectrometer, to instantly identify potentially deadly levels of opioids in local drug supplies.
-
Calming techniques officers learn during training for intervening in a mental health crisis don't seem to work as well when a suspect is high on meth. Police say meth calls can be much more dangerous.
-
The amount of meth seized in the U.S. more than doubled from 2017 to 2018. That translates to lots more meth, along with cocaine and other stimulants, on the streets — and likely more deaths.
-
Some physicians say connecting environmental effects of climate change — heat waves, more pollen and longer allergy seasons — to the health consequences helps them better care for patients.
-
A study looked at who gets prescriptions for buprenorphine, and found that white patients are almost 35 times as likely to get the lifesaving addiction treatment than African Americans.
-
The maker of OxyContin will pay to settle a historic opioid lawsuit brought by the attorney general of Oklahoma. Will other drugmakers named in the lawsuit follow?